Six Wall Street firms raised price targets on JCI after its Q1 earnings beat. Now options traders are swinging bullish. Short sellers are adding exposure — but the borrow market tells a different story.
The May 7 target hikes were broad and emphatic. UBS lifted its target to $170 from $160. Wells Fargo moved to $160 from $145. RBC Capital made the biggest relative move, jumping to $154 from $139. Barclays, Citigroup, and Mizuho all followed with raises of their own.
The mean analyst price target now sits at $151.19. JCI closed Thursday at $145.03. That implies roughly 4% upside to the consensus — modest, but the direction is clear. Two firms also initiated coverage in April: Evercore ISI at $155 (In-Line) and BNP Paribas at $120 (Underperform), the lone dissenting voice.
Wellington Management added over 5 million shares in Q1. That's the biggest institutional move in the top-15 holder list by a wide margin. BlackRock added 1.07 million shares through April. Invesco added 587,000. The institutional flow aligns with the analyst direction.
The put-call ratio dropped to 0.84 on May 14. The 20-day average is 0.98. That's a move of 2.0 standard deviations below the mean — the most bullish options positioning JCI has seen in recent weeks.
The shift is notable given the stock's Q1 earnings reaction. Shares fell 3.8% on May 6 when results were reported. The subsequent analyst upgrades reversed that quickly. JCI is now up 4.2% over the past week and 0.9% on Thursday alone.
Short interest climbed 14.1% over the past week to 1.40% of free float. That sounds large in percentage-change terms. In absolute terms, it's not. At 1.4% of float, short positioning in JCI is light.
The borrow market confirms this. Cost to borrow dropped 53% over the past week to 0.20% annually — near the floor. Availability is extremely loose. The ORTEX short score sits at 29.9 out of 100, well below any level that would suggest meaningful short-side pressure.
The short interest rise is more likely residual hedging than a directional short thesis. Nothing in the lending data supports a squeeze narrative.
See the live data behind this article on ORTEX.
Open JCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
